Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Click Coupling Chemistry to Explore Glycan Recognition. | ACS Cent Sci | 2025 | 40454341 | PubTator, text mining | PubMed |
| Mammalian Cell Surface Display for High-Throughput Protein Engineering of Glycosyltransferases. | Small | 2025 | 40417887 | PubTator, text mining | PubMed |
| Inhibitory effects of β-galactoside α2,6-sialyltransferase 1 on the Hippo pathway in breast cancer cells. | J Biol Chem | 2025 | 40409546 | PubTator, text mining | PubMed |
| Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells. | Immunity | 2025 | 40381622 | PubTator, text mining | PubMed |
| Identification and validation of glycosyltransferase-related gene signatures to predict prognosis and immunological characteristics of renal clear cell carcinoma. | Transl Androl Urol | 2025 | 40376527 | PubTator, text mining | PubMed |
| Glycosyltransferases: glycoengineers in human milk oligosaccharide synthesis and manufacturing. | Front Mol Biosci | 2025 | 40370521 | PubTator, text mining | PubMed |
| Harnessing the bishomolithocholic acid scaffold for selective sialyltransferase inhibition: A targeted approach to suppress breast cancer metastasis. | Eur J Med Chem | 2025 | 40324300 | PubTator, text mining | PubMed |
| Combined effect of areca nut, cigarettes, alcohol and SNPs in glycosyltransferase family genes on lung cancer development in Hainan, China. | BMC Cancer | 2025 | 40307723 | PubTator, text mining | PubMed |
| Comparative evaluation of methods for isolating extracellular vesicles from ICC cell culture supernatants: Insights into proteomic and glycomic analysis. | Cell Commun Signal | 2025 | 40301937 | PubTator, text mining | PubMed |
| Exomeres and supermeres: Current advances and perspectives. | Bioact Mater | 2025 | 40276541 | PubTator, text mining | PubMed |
| Correction to: miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1. | J Physiol Biochem | 2025 | 40186834 | PubTator, text mining | PubMed |
| Optimizing ST6GAL1 inhibition and selectivity using lithocholic acid-amino acid conjugates for antimetastatic and antiangiogenic agent development. | Bioorg Chem | 2025 | 40174529 | PubTator, text mining | PubMed |
| Novel insights into the genetic architecture and mechanisms of host/microbiome interactions from a multi-cohort analysis of outbred laboratory rats. | bioRxiv | 2025 | 40166210 | PubTator, text mining | PubMed |
| Acetylated Dendrobium huoshanense polysaccharide: a novel inducer of apoptosis in colon cancer cells via Fas-FasL pathway activation and metabolic reprogramming. | Front Oncol | 2025 | 40104499 | PubTator, text mining | PubMed |
| Profiling the regulatory landscape of sialylation through miRNA targeting of CMP- sialic acid synthetase. | J Biol Chem | 2025 | 40010608 | PubTator, text mining | PubMed |
| Exploring the relationship between sepsis and Golgi apparatus dysfunction: bioinformatics insights and diagnostic marker discovery. | Front Genet | 2025 | 39981259 | PubTator, text mining | PubMed |
| Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation. | Biomol Biomed | 2025 | 39937175 | PubTator, text mining | PubMed |
| Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma. | BBA Adv | 2025 | 39911812 | PubTator, text mining | PubMed |
| Spatial single-cell maps reveal ST6GAL1 promoting ovarian cancer metastasis. | Glycoconj J | 2025 | 39883364 | PubTator, text mining | PubMed |
| ST6GAL1-Mediated Sialylation of PECAM-1 Promotes a Transcellular Diapedesis-Like Process That Directs Lung Tropism of Metastatic Breast Cancer. | Cancer Res | 2025 | 39786386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=5